Translate
Haemonetics Corporation
About
Haemonetics Corporation (NYSE:HAE) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Apr 1 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Mar 30 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
Feb 23 2026
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Feb 20 2026
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Financials
Revenue
$1.32 B
Market Cap
$2.66 B
P/E Ratio
15.66
EPS
3.63